![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Shandong Jinyang Pharmaceutical Co., Ltd. Zibo City Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Oxytetracycline dihydrate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2004-177 - Rev 00
This Chemical Type CEP, issued on November 15, 2007, remains in force until June 01, 2012, ensuring its reliability within the pharmaceutical industry.
Substance Number 199 associated with this CEP further emphasizes